Grove Group

Grove Group Since 1996 Grove Group provides market entry solutions to the CEE countries. We improve patient access to innovative medications in the region by enabling

Russia and Bulgaria signed cooperation agreementLast week, on July 10, 2018, in Sofia Vladislav Shestakov – Director of ...
31/07/2018

Russia and Bulgaria signed cooperation agreement

Last week, on July 10, 2018, in Sofia Vladislav Shestakov – Director of the State Institute of Drugs and Good Practices, Deputy Head of the State GMP Inspectorate met with Professor Assena Stoimenova, Executive Director of the Bulgarian Drug Agency (Medicines Agency of the Bulgarian Health Ministry).

http://groveonline.com/russia-bulgaria-signed-cooperation-agreement/



Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgiumhttp://grove...
20/07/2018

Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium

http://groveonline.com/aurobindo-pharma-acquire-apotex-businesses-poland-czech-republic-netherlands-spain-belgium/

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Agile Pharma B. V. (Netherlands) has entered into an agreement on 13 July 2018 to acquire commercial operations and certain supporting infrastructure in five European countries viz. the Netherlands, Belgium, Spain, Poland and Czech Republic from Apotex International Inc. a Canadian pharmaceutical company engaged in the manufacture and marketing of pharmaceutical products.


Slovenia and Romania are the Fastest Growing Markets in Europehttp://groveonline.com/slovenia-romania-fastest-growing-ma...
12/07/2018

Slovenia and Romania are the Fastest Growing Markets in Europe
http://groveonline.com/slovenia-romania-fastest-growing-markets-europe/
Whilst the latest European Commission 2018 economic growth forecast for the EU stands at 2.3%, a large group of Eastern European countries clearly outpaces its European peers. Slovenia, Romania and Bulgaria lead the pack as shown on the chart below.


Whilst the latest European Commission 2018 economic growth forecast for the EU stands at 2.3%, a large group of Eastern European countries clearly outpaces its European peers. Slovenia, Romania and Bulgaria lead the pack as shown on the chart below.

Bulgaria’s Sopharma Trading to grow operations in Serbiahttp://groveonline.com/bulgarias-sopharma-trading-grow-operation...
04/07/2018

Bulgaria’s Sopharma Trading to grow operations in Serbia
http://groveonline.com/bulgarias-sopharma-trading-grow-operations-serbia/
SOFIA (Bulgaria), June 22 (SeeNews) - Bulgarian drug distributor and retailer Sopharma Trading [BUL:SO5] plans to expand its operations on the Serbian market and to become a strategic investor in Southeast Europe (SEE), it said.


SOFIA (Bulgaria), June 22 (SeeNews) - Bulgarian drug distributor and retailer Sopharma Trading [BUL:SO5] plans to expand its operations on the Serbian market and to become a strategic investor in Southeast Europe (SEE), it said.

Sun Pharma enters Azerbaijani markethttp://groveonline.com/sun-pharma-enters-azerbaijani-market/Azerbaijan’s Sumgait cit...
26/06/2018

Sun Pharma enters Azerbaijani market
http://groveonline.com/sun-pharma-enters-azerbaijani-market/
Azerbaijan’s Sumgait city has hosted the groundbreaking ceremony of the first plant for the production of solid drugs.
The ceremony was attended by Azerbaijan’s Economy Minister Shahin Mustafayev.


During the event, it was noted that products of the plant, which is being built by India’s Sun Pharmaceutical Industries Ltd. (Sun Pharma), will meet the European GMP (Good Manufacturing Practice) standards.

Poland might not be the first place you associate with biotech, but the country is becoming an emerging hotspot for phar...
19/06/2018

Poland might not be the first place you associate with biotech, but the country is becoming an emerging hotspot for pharmaceutical companies and biotech startups
http://groveonline.com/poland-place-associate-biotech-country-emerging-hotspot-pharmaceutical-companies-biotech-startups/
Although Poland has a very strong scientific base in life sciences and medicine, it has not developed a vibrant biotech or medtech sectors. Until recently, no truly innovative products from Poland have been introduced to the global market.


Czech Republic mulls new reimbursement rules for medical deviceshttp://groveonline.com/czech-republic-mulls-reimbursemen...
29/05/2018

Czech Republic mulls new reimbursement rules for medical devices
http://groveonline.com/czech-republic-mulls-reimbursement-rules-medical-devices/
The Czech Health Ministry prepared draft amendments to the Public Health Insurance Act, which will introduce new reimbursement rules for medical devices, the Ministry said.


The Czech Health Ministry prepared draft amendments to the Public Health Insurance Act, which will introduce new reimbursement rules for medical devices, the Ministry said.

Medicines rose in price in Kazakhstanhttp://groveonline.com/medicines-rose-price-kazakhstan/Medicines in Kazakhstan rose...
25/05/2018

Medicines rose in price in Kazakhstan
http://groveonline.com/medicines-rose-price-kazakhstan/
Medicines in Kazakhstan rose by 7% in 2018 Q1, Energyprom.kz reports. According to 2018 first quarter results, prices for pharmaceutical products rose 2% compared to the previous quarter and by 6.6% on-year.


Lithuania – Update on ‘Sunset Clause’ Requirements for Medicinal Productshttp://groveonline.com/lithuania-update-sunset-...
10/05/2018

Lithuania – Update on ‘Sunset Clause’ Requirements for Medicinal Products
http://groveonline.com/lithuania-update-sunset-clause-requirements-medicinal-products/
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.


The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.

New payment requirements of a Bulgarian Drug Agencyhttp://groveonline.com/payment-requirements-bulgarian-drug-agency/In ...
08/05/2018

New payment requirements of a Bulgarian Drug Agency
http://groveonline.com/payment-requirements-bulgarian-drug-agency/
In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives.


In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives.

Kazakh domestic pharmaceutical production up 79.8 percent in 2017http://groveonline.com/kazakh-domestic-pharmaceutical-p...
27/04/2018

Kazakh domestic pharmaceutical production up 79.8 percent in 2017
http://groveonline.com/kazakh-domestic-pharmaceutical-production-79-8-percent-2017/
ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016.

Kazakh domestic pharmaceutical production up 79.8 percent in 2017
http://groveonline.com/kazakh-domestic-pharmaceutical-production-79-8-percent-2017/
ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016.


ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016. Prices for pharmaceutical products in Kazakhstan have also increased 6.6 percent over the last 12 months.

Romania on the last place in EU for medical drugs consumptionhttp://groveonline.com/romania-place-eu-medical-drugs-consu...
19/04/2018

Romania on the last place in EU for medical drugs consumption
http://groveonline.com/romania-place-eu-medical-drugs-consumption/
Romania is at the bottom of a European ranking regarding the consumption of medical drugs per capita, but not because they are healthier, but due to the precarious access to therapeutic solutions, according to the Trade Union of Industrial Medical Drugs Producers in Romania (PRIMER).


Romania is at the bottom of a European ranking regarding the consumption of medical drugs per capita, but not because they are healthier, but due to the precarious access to therapeutic solutions, according to the Trade Union of Industrial Medical Drugs Producers in Romania (PRIMER).

http://groveonline.com/falsified-meds-impose-threat-hungary-eu/Falsified meds do not yet impose a serious threat in Hung...
13/04/2018

http://groveonline.com/falsified-meds-impose-threat-hungary-eu/
Falsified meds do not yet impose a serious threat in Hungary and the EU
“Due to strict regulations and legislatory monitoring no falsified or unauthorized medication has entered the legal drug supply chain in Hungary until now, stated the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM)



“Due to strict regulations and legislatory monitoring no falsified or unauthorized medication has entered the legal drug supply chain in Hungary until now, stated the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM).

Overview of Estonian medicinal products markethttp://groveonline.com/overview-estonian-medicinal-products-market-3/Eston...
05/04/2018

Overview of Estonian medicinal products market
http://groveonline.com/overview-estonian-medicinal-products-market-3/
Estonian annual drug statistics is based on wholesalers’ quarterly reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions



In 2017, 31 wholesalers sold human medicines to general or hospital pharmacies or to other institutions. Three major wholesalers covered 76% of human medicinal products market: Magnum Medical (29%), Tamro Estonia (26%) and Apteekide Koostöö Hulgimüük (21%). Followed by Roche Estonia (6%), Estoni...

http://groveonline.com/kazakhstan-pharmaceutical-medical-device-market-trends/Kazakhstan Pharmaceutical and Medical Devi...
22/03/2018

http://groveonline.com/kazakhstan-pharmaceutical-medical-device-market-trends/
Kazakhstan Pharmaceutical and Medical Device Market Trends
The Kazakhstan pharmaceutical and medical device industries are one of the most buoyant sectors of the country’s economy. Over the past three years, the productivity of the indigenous pharmaceutical industry has increased by 42%. In 2017, the value of domestically produced drugs exceeded 73 billion tenge...


The Kazakhstan pharmaceutical and medical device industries are one of the most buoyant sectors of the country’s economy. Over the past three years, the productivity of the indigenous pharmaceutical industry has increased by 42%. In 2017, the value of domestically produced drugs exceeded 73 billio...

Regarding medicinal products for which „sunset clause“ may already be appliedhttp://groveonline.com/medicinal-products-s...
19/03/2018

Regarding medicinal products for which „sunset clause“ may already be applied
http://groveonline.com/medicinal-products-sunset-clause-applied/
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.


The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.

http://groveonline.com/serbia-perspectives-pharmaceuticals-medical-devices/Serbia – New Perspectives for Pharmaceuticals...
07/03/2018

http://groveonline.com/serbia-perspectives-pharmaceuticals-medical-devices/
Serbia – New Perspectives for Pharmaceuticals and Medical Devices
With Serbia making further progress with the EU accession process and the prospect of joining the EU in 2025, it is the country which gets increased attention of international pharmaceutical and medical device manufacturers.


"It is the process of joining the European Union that counts and not so much the date that Serbia joins" - Sanja Ivanic, CCFS

http://groveonline.com/azerbaijan-jordan-jointly-produce-pharmaceuticals/Azerbaijan, Jordan may jointly produce pharmace...
01/03/2018

http://groveonline.com/azerbaijan-jordan-jointly-produce-pharmaceuticals/
Azerbaijan, Jordan may jointly produce pharmaceuticals
Azerbaijan offers Jordan to establish a joint pharmaceutical factory, Jordan Economy Ministry said on Feb. 21.

Azerbaijan’s Economy Minister Shahin Mustafayev made an offer during the meeting with Jordan Minister of Industry, Trade and Supply Yarub Qudah in the framework of working visit to Jordan.


Azerbaijan’s Economy Minister Shahin Mustafayev made an offer during the meeting with Jordan Minister of Industry, Trade and Supply Yarub Qudah in the framework of working visit to Jordan.

Address

Cawley Place, 15 Cawley Road, Chichester, West Sussex 1UZ
Chichester
PO19

Alerts

Be the first to know and let us send you an email when Grove Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Grove Group:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram